CODX vs NDSN · rev $3.9M vs P/E 31, rev $2.69B
Co-Diagnostics, Inc. Common Stock (CODX) versus Nordson Corporation (NDSN) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
Nordson Corporation (NDSN) is a specialty industrial machinery company listed on NASDAQ.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported NDSN revenue for 2024-10-31 was $2.69B. Net income was $467.3M. Revenue was up 2.3% from 2023-10-31 to 2024-10-31. NDSN currently screens at market cap $16.17B and trailing P/E 31.0.
CODX currently screens at market cap $31.4M. NDSN currently screens at market cap $16.17B and trailing P/E 31.0.
Not investment advice. Open the CODX and NDSN stock pages for the full models.
Not investment advice.